medicalxpress - Ten years and thousands of patient samples later, the National Cancer Institute (NCI) has published its results from the Human Cancer Model Initiative (HCMI) on the development of 665 organoid models of 25 types of cancer that are now available to scienti…
AI Summary: An international consortium released hundreds of patient‑derived tumor models, including a public HCMI set of 665 organoids, creating a living biobank for drug discovery. Labs worldwide now gain access to diverse, next‑generation models to test therapies and probe cancer vulnerabilities — a major boost for preclinical translational work.
Some tumors kill neighboring healthy cells to fuel growth / 2 months
MYC overactivity enables DNA repair and chemotherapy resistance in tumours / 3 months
Enhertu (DESTINY‑Lung04) improves PFS in HER2‑mutant lung cancer / 6 days
Engineered bacteria show promise as tumor‑targeting therapy in preclinical studies / 5 wks
Daraxonrasib shows encouraging activity in NRAS-driven melanoma patients / 6 wks
St. Jude pins RBM5 as a leukemia driver and therapeutic target / 6 wks
CAR‑T depletes mutant calreticulin cells, offering myelofibrosis hope / 1 month
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.